The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Thrombin Time testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Thrombin Time testing closer to the patient, creating additional opportunities and challenges for suppliers.
This report presents a detailed analysis of the Thrombin Time testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.Contains 196 pages and 8 tables
SIMILAR MARKET STUDIES
Complete report $2,250. DataPack (test volumes, sales forecasts, supplier shares) $1,450.RationaleThe use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the ...
September 2015 | $1450 | View Details >>
This 106-page report presents an overview of the clinical significance and market needs for major hematology and flow cytometry procedures.The report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 106 pages
November 2015 | $0 | View Details >>
This unique report from VPGMarketResearch provides France sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, ...
June 2015 | $1260 | View Details >>
This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next five years. The report explores business and technological trends in ...
June 2014 | $7500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research